Perry A Karsen's Net Worth
Perry A Karsen's net worth is estimated to be at least $21,802,539.40 as of 05/04/2024. CoreStreet's estimation of Perry A Karsen's net worth is based on their sale of stock and current holding of stock.
Perry A Karsen is Director at Intellia Therapeutics Inc. They have executed at least 3 trades of stock as per SEC Form 4 filings. Their most recent trade was for 88,764 units of NTLA stock on 12/17/2020. Their biggest sale was on 08/02/2013 when they sold 93,008 units of Bristol-Myers Squibb Company stock for $13,625,672.00. They typically trade 1 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $21,802,539.40
Most recent insider trade:
- Dec. 17, 2020
Perry A Karsen's Insider Trading History
| Intellia Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 17, 2020 | Director | 88,764 | $53.55 | Sell | $4,753,312.20 |
| Bristol-Myers Squibb Company | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 4, 2014 | Insider | 39,104 | $87.55 | Sell | $3,423,555.20 |
Aug. 2, 2013 | Insider | 93,008 | $146.50 | Sell | $13,625,672.00 |